Preclinical Research and Development

Identifying the drug candidates that have the best efficacy, lowest toxicity and novel mechanisms of action, requires highly focused technical teams to be successful. The staff of SRA Life Sciences’ has an average 13 years experience in preclinical assays and assay development from clinical and research diagnostics, to molecular and cellular toxicology, to in vitro pharmacokinetics. This expertise has supported clients in obtaining INDs and advancing drug development candidates into clinical trials. Our Preclinical Research and Development team will continue to help you maintain the highest level of excellence and efficiency all the way through clinical development.

  • Microbiology
  • Cellular & Molecular Immunology
  • Virology
  • Molecular Biology
  • Molecular Toxicology
  • Immunotoxicology
  • In Vitro Pharmacokinetics
  • Mutational Analysis
  • Quantitative Mutational Analysis SystemSM (QMASSM)
  • Oncology & Cell Biology
  • Drug Resistance

Leave a Reply

Your email address will not be published. Required fields are marked *